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We report that three (EF0089, EF2505 and EF1896, renamed here Fss1, Fss2 and Fss3,
respectively, for Enterococcus faecalis surface protein) of the recently predicted MSCRAMMs
(microbial surface components recognizing adhesive matrix molecules) in E. faecalis strain V583
bind fibrinogen (Fg). Despite an absence of extensive primary sequence homology, the three
proteins appear to be related structurally. Within the N-terminal regions of the three enterococcal
proteins, we identified pairs of putative IgG-like modules with a high degree of predicted
structural similarity to the Fg-binding N2 and N3 domains of the staphylococcal MSCRAMMs
ClfA and SdrG. A second N2N3-like segment was predicted in Fss1. Far-UV circular dichroism
spectroscopy revealed that all four predicted N2N3-like regions are composed mainly of b-sheets
with only a minor proportion of a-helices, which is characteristic of Ig-like folded domains. Three of
the four identified enterococcal N2N3-like regions showed potent dose-dependent binding to Fg.
However, the specificity of the Fg-binding MSCRAMMs differs, as indicated by far-Western blots,
which showed that recombinant segments of the MSCRAMMs bound different Fg polypeptide
chains. Enterococci grown in serum-supplemented broth adhere to Fg-coated surfaces, and
inactivation in strain OG1RF of the gene encoding Fss2 resulted in reduced adherence, whilst
complementation of the mutant restored full Fg adherence. Thus, E. faecalis contains a family of
MSCRAMMs that structurally and functionally resemble the Fg-binding MSCRAMMs of
staphylococci.
INTRODUCTION
Enterococcus faecalis is a component of the human
commensal flora, but is also emerging as an opportunistic
pathogen and has become one of the leading causes of
nosocomial infections in developed countries (Murray &
Weinstock, 1999). E. faecalis can cause a variety of
infections, of which endocarditis, wound and bloodstream
infections are the most serious. Treatment of enterococcal
infections is complicated by the increased presence of
multiple antibiotic-resistance genes in infection-associated
enterococcal strains (Malathum & Murray, 1999; Murray,
2000). These resistance determinants are frequently carried
on mobile DNA elements (Paulsen et al., 2003) and can
easily be exchanged between different strains, leading to
rapid dissemination of antibiotic resistance among
enterococci.
During infection, enterococci are thought to be located
primarily extracellularly in tissues and thus are likely to
adhere to the extracellular matrix (ECM) of the host. The
attachment of different E. faecalis strains to several
different ECM proteins has also been reported
(Rozdzinski et al., 2001; Styriak et al., 1999, 2002; Tomita
& Ike, 2004; Xiao et al., 1998; Zareba et al., 1997).
However, the MSCRAMMs (microbial surface components
recognizing adhesive matrix molecules) responsible for
these interactions have generally not been identified and
Abbreviations: CD, circular dichroism; ECM, extracellular matrix; Fg,
fibrinogen; MSCRAMMs, microbial surface components recognizing
adhesive matrix molecules; RBS, ribosome-binding site.
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characterized. An exception is the collagen adhesin Ace,
which was identified based on its sequence similarity to the
collagen-binding MSCRAMM Cna from Staphylococcus
aureus (Nallapareddy et al., 2000; Rich et al., 1999).
Staphylococci express a family of structurally related, cell
wall-anchored proteins that act as MSCRAMMs and bind
to fibrinogen (Fg), collagen, fibronectin, laminin, cytoker-
atin 10 and elastin (Davis et al., 2001; Jo¨nsson et al., 1991;
McDevitt et al., 1994; Nallapareddy et al., 2000, 2003; Ni
Eidhin et al., 1998; O’Brien et al., 2002; Patti et al., 1992;
Rich et al., 1999; Roche et al., 2004; Signa¨s et al., 1989;
Wann et al., 2000). The recognized staphylococcal
MSCRAMMs contain an N-terminal A-region composed
of three domains, of which at least two adopt a
characteristic IgG-like fold. The A-region is followed by a
variable region that often includes tandemly repeated
sequences that, in some cases, can also adopt IgG-like folds
(Deivanayagam et al., 2000). At their C termini, these
bacterial surface proteins contain a set of conserved motifs
required for cell-wall anchoring, including an LPXTG-like
motif followed by a hydrophobic membrane-spanning
region and a short stretch of positively charged amino acid
residues. A transpeptidase called sortase recognizes the
LPXTG motif and catalyses the covalent attachment of the
threonine residue to the peptidoglycan of the cell wall
(Mazmanian et al., 2001; Navarre & Schneewind, 1999;
Schneewind et al., 1992).
The A-region contains the primary ligand-binding
domains in the staphylococcal MSCRAMMs, and bio-
chemical studies have shown that two IgG-folded domains
are sufficient for ligand binding. The crystal structure of
the ligand-binding domain of the Fg-binding MSCRAMM
SdrG from Staphylococcus epidermidis has been solved, both
as an apoprotein and in complex with an Fg-based ligand
peptide (Deivanayagam et al., 2000; Ponnuraj et al., 2003).
These structures reveal that the ligand peptide can dock at
the interphase between domains 2 and 3 (called N2 and
N3). As the ligand peptide docks, the C-terminal extension
of N3 is redirected in the complex to cover and lock the
bound peptide in the ligand-binding pocket. Furthermore,
the N3 extension is inserted into a trench on the surface of
the N2 module, where it stabilizes the complex by serving
as a latch. The bottom of the latching trench contains a
characteristic sequence motif, TYTFTDYVD, which is
conserved in a similar location in other staphylococcal
MSCRAMMs, as well as the enterococcal MSCRAMMs Ace
(E. faecalis) and Acm (Enterococcus faecium) (McCrea et al.,
2000; Nallapareddy et al., 2003; Ponnuraj et al., 2003).
In an effort to identify other putative enterococcal
MSCRAMMs, we previously searched the published
genome of E. faecalis V583 for cell wall-anchored proteins
with MSCRAMM-like characteristics (Sillanpa¨a¨ et al.,
2004). We have identified 17 putative cell wall-anchored
proteins containing predicted repeated IgG-folded mod-
ules. However, in enterococci, the putative A-regions vary
in length from two modules (Ace) to seven to ten modules
(EF0089, EF2505 and EF1896, renamed here Fss1, Fss2 and
Fss3, respectively), compared with the consistent number
of three IgG-folded domains found in the A-regions of
staphylococcal MSCRAMMs. In the current study, we have
investigated the binding of 11 of the identified
MSCRAMM-like enterococcal proteins to a selection of
host proteins. Recombinant segments of three
MSCRAMMs bound Fg with reasonable affinity.
Furthermore, the minimal ligand-binding sites in these
three enterococcal proteins were identified by comparison
of predicted structural similarities to solved crystal
structures of ClfA and SdrG. The predicted binding
domains were expressed and characterized further.
METHODS
Bacterial strains, plasmids and growth conditions. E. faecalis and
Escherichia coli strains and plasmids used for E. faecalis gene
disruption and complementation studies are listed in Table 1.
Enterococci were grown routinely in brain–heart infusion (BHI) or
Todd–Hewitt (TH) broth/agar (Difco) and E. coli in Luria–Bertani
(Difco) media at 37 uC. The antibiotics used with enterococci were
erythromycin (5 mg ml21) and kanamycin (2000 mg ml21), and with
E. coli, ampicillin (100 mg ml21), kanamycin (50 mg ml21) and
erythromycin (200 mg ml21).
Construction of expression plasmids. The sequenced E. faecalis
strain V583 (Sahm et al., 1989) was used as a template for the
construction of protein expression plasmids. Primers for cloning
PCR-generated DNA fragments into the expression vector pQE30
(Qiagen) are listed in Table 2 and the cloned regions are shown in Fig.
2(a). Isolation of genomic DNA from strain V583 and other cloning
procedures were performed as described previously (Sillanpa¨a¨ et al.,
2004).
Expression and purification of His6-tagged proteins. Expression
cultures were induced with IPTG and the N-terminally His6-tagged
proteins were purified by using nickel-affinity chromatography and
anion-exchange chromatography as described previously (Sillanpa¨a¨ et
al., 2004). Purified proteins were dialysed extensively against PBS,
pH 7.4, and stored at 220 uC. Protein concentrations were
determined by measuring A280 by spectroscopy, using calculated
molar absorption coefficient values (Pace et al., 1995). Molecular
masses of the expressed proteins were confirmed with MALDI-TOF
mass spectrometry (Tufts University mass spectrometry facility, MA,
USA) from protein samples in H2O.
ELISA-type ligand-binding assays. Binding of recombinant
enterococcal proteins to components of the ECM {mouse laminin
[Roche Diagnostics], human fibronectin [purified from plasma in our
laboratory as described by Wann et al. (2000)], human Fg
[plasminogen-, von Willebrand factor- and fibronectin-depleted
(Enzyme Research Laboratories)], collagen type I [bovine (Vitrogen
100; Collagen Biomaterials)] and collagen type III and IV [human
placenta (Sigma)]} was tested in ELISA-type assays. Microplate
(4HBX; Thermo Scientific) wells were coated with 1 mg of each ECM
protein in 100 ml TBS [0.05 M Tris–HCl, 0.9% (w/v) NaCl, pH 7.5]
or 3% acetic acid for collagens, overnight at 4 uC. The plates were
washed once with TBS and the remaining protein-binding sites were
blocked by 1 h incubation with 2% BSA, 0.1% Tween 20 in TBS
(blocking buffer). Purified His6-tagged proteins (50 ml of 10 mM or
increasing concentrations) in blocking buffer were added and
incubated at ambient temperature for 2 h. Plates were washed three
times with 0.1% Tween 20 in TBS and incubated for 1 h with 100 ml
of a 1 : 3000 dilution of monoclonal anti-His6 antibody (GE
Fibrinogen-binding proteins from Enterococcus faecalis
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Table 1. Bacterial strains and plasmids used in this study
Strain/plasmid Relevant characteristics* Reference or source
Strains
Enterococcus faecalis
OG1RF Wild-type; Kans Murray et al. (1993)
V583 Sequenced strain; blood isolate; Vanr, Genr, Kanr, Eryr, Strr Paulsen et al. (2003);
Sahm et al. (1989)
TX5450 OG1RF fss2 : : pTEX5446; fss2 insertion disruption mutant of OG1RF; Kanr This study
TX5487 TX5450 harbouring plasmid pMSP3535; Eryr, Kanr (control for complementation) This study
TX5488 TX5450 harbouring plasmid pTEX5486; Eryr, Kanr (complementation with the fss2 gene) This study
Escherichia coli
M15(pREP4) E. coli cloning and expression host; Ampr, Kanr Qiagen
DH5a E. coli cloning host Stratagene
TG1 E. coli cloning host Sambrook et al. (1989)
TX5446 DH5a (pTEX5446); Kanr This study
TX5486 TG1 (pTEX5486); Eryr This study
Plasmids
pTEX4577 Derived from pBluescript SK2, used for insertion disruption mutagenesis in
enterococci; Kanr
Singh et al. (1998)
pMSP3535 Shuttle plasmid used for complementation, with nisin-inducible promoter Bryan et al. (2000)
pTEX5446 Intragenic fss2 fragment cloned into pTEX4577 This study
pTEX5486 Construct for complementation; a 4956 bp fragment containing fss2 amplified from
strain V583 cloned into pMSP3535; Eryr
This study
*Amp, Ampicillin; Ery, erythromycin; Gen, gentamicin; Kan, kanamycin; Van, vancomycin; Str, streptomycin. For enterococci, Kanr indicates
MIC .2000 and Kans, MIC ¡2000.
Table 2. Primers used in this study
Function* Primer name Sequence (5§A3§)D
Fss1 protein expression Fss1 36F CCGAGCTCGAAGAGGTTAACAGCGATGG
Fss1 220F GCGGGATCCGAAACAACGATTATCGATAATTT
Fss1 757F GCGGCATGCAACAATCCTGCGTTGGACCAT
Fss1 550R GCGGTCGACTTAATTATCCCCCATTGTGTCTG
Fss1 1090R CGCCTGCAGTTACCCGCCACTGTGATCAATGT
Fss1 1143R CCCTGCAGTTACCCACCAAATGTGATAACCC
Fss2 protein expression Fss2 28F GCGGGATCCGTAACAACGACAGAAGCACAA
Fss2 111F GCGGGATCCCAAGCGCCAATTACAGATGA
Fss2 429R GCGCTGCAGTTAAATTGTTACATAATATTTCCCTT
Fss2 449R GCGCTGCAGTTAACCGTTTGTACTCTCTAATAC
Fss3 protein expression Fss3 267F GCGGGATCCAACACTTACACGGTCAAAATTG
Fss3 273F GCGGGATCCATTGATGTAGAAACCGAGGGT
Fss3 586R GCGGTCGACTTAGCCTAATTGCTCATTATAAGCT
Fss3 681R GCGGTCGACTTATCCTTCTGGCGCTTCTACTT
Fss3 971R GCGGTCGACTTAATCTACTTTTTCCGCAAGCATA
Disruption mutant, intragenic fss2 Fss2 F CCGGAATTCAGTTATCGAACTCAACACCATCTTTAC
Fss2 R CGGGGTACCACTTGAGGTTCCAAGTTATCTTGTTTT
Complementation, complete fss2 gene including RBS Fss2ComF1 GGATCCGAATTTTATTGAAAGGGGATT
Fss2ComR1 GCACCGTTTGTAGTCTTCTC
Fss2ComF2 CAACGATTGAATTAACACCA
Fss2ComR2 CTGCAGAAATAGTTCGCTGGTTCATC
*See Table 1 and Fig. 2 for cloned and expressed regions.
DIntroduced restriction sites are underlined; the stop codon is italicized.
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Healthcare) in blocking buffer. After three washes, 100 ml of a 1 : 3000
dilution of alkaline phosphatase-conjugated anti-mouse antibody
(Bio-Rad) in blocking buffer was added to the wells and incubated for
1 h. Finally, the plate was developed with 1 mg p-nitrophenyl
phosphate ml21 (Sigma) in 0.1 M diethanolamine buffer, pH 9.8,
containing 1 mM MgCl2. A405 was measured with a microplate reader
(ThermoMax; Molecular Devices).
Far-Western blot analysis. To test binding of His6-tagged
recombinant proteins to the individual a, b and c polypeptide chains
of Fg, 1 mg Fg per lane was fractionated by SDS-PAGE and transferred
to a nitrocellulose membrane (0.45 mm) with a semi-dry transfer cell
(Bio-Rad). The membranes were blocked with 2% BSA, 0.1% Tween
20 in PBS at 4 uC overnight. After three washes with PBS containing
0.05% Tween 20, the membranes were incubated with 100 mg His6-
tagged recombinant proteins ml21 in 1% BSA, 0.05% Tween 20 in
PBS for 2 h at room temperature. Bound protein was detected with a
1 : 3000 dilution of monoclonal anti-His6 antibody (GE Healthcare),
followed by a 1 : 5000 dilution of alkaline phosphatase-conjugated
anti-mouse antibody (Bio-Rad). The phosphatase substrates nitro
blue tetrazolium and BCIP (5-bromo-4-chloro-3-indolyl-phosphate)
(Bio-Rad) in 0.1 M NaHCO3, 1 mM MgCl2, pH 9.8, were used for
signal detection.
Analysis of secondary-structure components. Far-UV circular
dichroism (CD) spectroscopy data were collected from protein samples
in 10 mM potassium phosphate buffer, pH 7.4, as described previously
(Sillanpa¨a¨ et al., 2004). Twenty scans were averaged for each spectrum
and the contribution of buffer was subtracted. Quantification of
secondary-structure components was performed by analysing the
spectra with a combination of three deconvolution algorithms,
SELCON3, ContinLL and K2D, using the DICHROWEB server (http://
www.cryst.bbk.ac.uk/cdweb/html/home.html) (Lobley et al., 2002;
Whitmore & Wallace, 2004).
Construction of disruption mutants and complementation.
Gene disruptions were achieved by the method described previously
(Qin et al., 1998; Singh et al., 1998). An internal fragment of fss2 was
amplified from E. faecalisOG1RF genomic DNA using primers listed in
Table 2 and cloned into pTEX4577 (Singh et al., 1998), according to
standard methods (Sambrook et al., 1989). The resulting construct has
the plasmid integrated between the codons encoding aa 301 and 302,
located within the N2N3-like region. This construct was electroporated
(Li et al., 1995) into E. faecalis OG1RF, followed by selection on TH
agar plates with 2000 mg kanamycin ml21 to generate TX5450. Correct
insertion was confirmed by PCR, PFGE and Southern blot analysis
(Nallapareddy et al., 2000; Qin et al., 1998). Growth curves, as well as
stability of single-crossover disruptions in mutants, were determined as
described previously (Nallapareddy et al., 2000).
A construct for complementation was generated with the shuttle
vector pMSP3535, which contains a nisin-inducible promoter (Bryan
et al., 2000). Briefly, two DNA fragments containing the complete fss2
gene and its ribosome-binding site (RBS) were amplified (the first
fragment with primers Fss2ComF1 and Fss2ComR1 and the second
with Fss2ComF2 and Fss2ComR2; see Table 2) from genomic DNA of
the sequenced strain E. faecalis V583 (Paulsen et al., 2003) and cloned
into the pGEM-T Easy vector (Promega). The first and second
fragments were released by using BamHI–EcoRI and EcoRI–PstI
restriction enzymes, respectively, and then ligated with BamHI–PstI-
digested pMSP3535. This in vitro-ligated construct for complementa-
tion (designated pTEX5486) was transformed into E. coli TG1 to
obtain TX5486 and was then introduced into electrocompetent cells
of TX5450.
Production and purification of Fss2-specific antibodies.
Polyclonal antibodies against rFss2(28–449) were raised in rabbit and
purified from rabbit serum by affinity chromatography with rFss2(28–
449) coupled to cyanogen bromide-activated Sepharose 4B, as
described previously (Sillanpa¨a¨ et al., 2008).
Flow cytometry. To determine surface expression of Fss2 by flow
cytometry, bacteria were grown for 10 h in BHI broth supplemented
with 40% horse serum from an inoculum with an OD600 of 0.01.
Collected and washed cells were labelled with purified preimmune or
Fss2-specific antibodies followed by R-phycoerythrin-conjugated
F(ab9)2 fragment goat anti-rabbit IgG, as described previously
(Kemp et al., 2007; Sillanpa¨a¨ et al., 2008). Cells were fixed with 1%
paraformaldehyde in PBS and analysed with a Coulter EPICSXL
AB6064 flow cytometer (Beckman Coulter) and System II software.
Adherence of radiolabelled E. faecalis to immobilized Fg.
Bacteria grown for 10 h in 5 ml BHI broth with 40% horse serum
(Nallapareddy & Murray, 2008) and Tran35S label [10 mCi (370 kBq)
ml21; MP Biochemicals] were harvested, washed three times in PBS
and resuspended in 0.5% Tween 80, 0.1% BSA in PBS. For the
complemented strain (TX5488) and the vector control (TX5487),
nisin was added to the growth medium at a final concentration of
25 ng ml21. Immulon 1 Removawells (Dynatech Laboratories),
coated overnight with Fg at 4 uC (at a concentration of 1 mg per
well), were blocked with 200 ml 0.2% BSA for 2 h with gentle shaking.
Labelled bacteria (50 ml, adjusted to an OD600 of 0.2) were added to
wells and allowed to incubate at room temperature for 2 h with gentle
shaking. Wells were then washed with 0.5% Tween 80, 0.1% BSA in
PBS three times. The radioactivity of bound cells in each detachable
well was measured in a liquid scintillation counter. To determine the
total amount of radioactivity added to each well, the radioactivity in a
sample of labelled bacteria (50 ml, adjusted to an OD600 of 0.2) was
measured. Percentage adherence was calculated with the following
equation: adherent bacteria (%)5(radioactivity of bound cells/
radioactivity of total cells added)6100 (Nallapareddy et al., 2000).
BSA-coated wells were used as negative controls.
Statistical analysis. To compare sample means, an unpaired t-test
was used. P,0.05 was considered statistically significant. Statistical
tests were performed by using GraphPad Prism v4.
RESULTS
Recombinant segments of Fss1, Fss2 and Fss3
bind to immobilized human Fg
We have initiated a search for ligands of the orphan E.
faecalis MSCRAMMs identified in the V583 genome.
Initially, the non-repeated regions were cloned and
expressed in E. coli as N-terminally His6-tagged fusion
proteins from eight of the 17 cell wall-anchored proteins,
Fss1 (EF0089), EF1091, EF1092, EF1093, EF1099, EF1269,
EF1824 and EF3023, that we have described previously
(Sillanpa¨a¨ et al., 2004). We recently reported that three of
these proteins, EF1091, EF1092 and EF1093 (subsequently
renamed EbpA, EbpB and EbpC, respectively), are pilus
subunit proteins that are important for biofilm formation,
as well as experimental endocarditis and urinary-tract
infections (Kemp et al., 2007; Nallapareddy et al., 2006;
Singh et al., 2007). We also expressed segments from three
additional proteins: Fss2 (EF2505; aa 111–449), Fss3
(EF1896; aa 267–971) and EF2347 (aa 272–680), which
we subsequently identified as putative cell wall-anchored
Fibrinogen-binding proteins from Enterococcus faecalis
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proteins with predicted IgG-like folded modules, but
with atypical cell wall-anchoring motifs. Purified fragments
of the 11 proteins were then tested for binding to a
selection of ECM proteins, including Fg, fibronectin,
laminin and type I, III and IV collagens, in an ELISA-
type ligand-binding assay. Three of the 11 protein
segments, rFss1(36–1143), rFss2(111–449) and rFss3(267–971),
showed binding to human Fg, compared with BSA and the
other ECM proteins included in this assay (Fig. 1), whilst
the remaining eight proteins showed no significant binding
to any of the other ECM proteins tested (data not shown).
These three proteins were selected for further structural
and functional analysis.
Domain organization of the Fg-binding proteins
Fss1, Fss2 and Fss3
As shown in Fig. 2(a), Fss1, Fss2 and Fss3 are predicted to
have a similar overall structural organization to the
previously described staphylococcal MSCRAMMs. The
putative N-terminal signal-peptide sequences of Fss1,
Fss2 and Fss3, which range from 27 to 35 aa in length,
are followed by non-repeated A-regions that vary in length
from 740 to 1107 aa. Analyses of their structures with two
complementing fold-recognition servers, 3D-PSSM (http://
www.sbg.bio.ic.ac.uk/~3dpssm/index2.html) and PHYRE
(http://www.sbg.bio.ic.ac.uk/~phyre/index.cgi) (Kelley
et al., 2000), showed that the A-regions of these proteins
are predicted to contain tandem repeats of IgG-like
modules. At the C-terminal end, Fss1 contains nine
sequence repeats of 73–102 aa (Sillanpa¨a¨ et al., 2004) that
show amino acid sequence and predicted structural
similarity to the IgG-like folded B-repeats of the col-
lagen-binding S. aureus MSCRAMM Cna. Similarly, Fss2
contains seven C-terminal tandem repeats ranging from 66
to 85 aa in length that are similar to the B-repeats of Cna
and are predicted to be IgG-folded. No conserved sequence
repeats were identified in the C-terminal region of Fss3. All
three proteins have putative cell wall-anchoring motifs at
their C termini.
The three Fg-binding proteins contain potential
MSCRAMM N2N3-like regions
Amino acid sequence comparisons between the A-regions
of the E. faecalis proteins Fss1, Fss2 and Fss3 and the
staphylococcal Fg-binding MSCRAMMs ClfA, ClfB, FnbpA
and SdrG did not reveal extensive sequence similarities. We
therefore decided to search for structural similarities
between the determined crystal structures of the minimal
Fg-binding N2N3-segments of ClfA (Deivanayagam et al.,
2002) and SdrG (Ponnuraj et al., 2003) and the predicted
structures of the E. faecalis proteins. A segment of the A-
region of Fss1 corresponding to aa 220–559 gave a strong
match to the Fg-binding N2N3 domains of ClfA
(e51.761028) using the 3D-PSSM server (Fig. 2a)
(Sillanpa¨a¨ et al., 2004). Using the PHYRE server, a
corresponding region (Fss1 aa 204–491) was predicted to
have structural similarity to ClfA N2N3 (e52.8610214).
Surprisingly, we found a second segment in the large Fss1
A-region that shows structural similarity to the N2N3
domains of ClfA (Fss1 aa 770–1074; e55.061029, PHYRE)
and SdrG (Fss1 aa 767–1090; e58.061023, 3D-PSSM). Fss2
was predicted to contain a ClfA N2N3-like segment from
aa 111 to 449 using the 3D-PSSM program (e51.761028)
and from aa 105 to 386 using PHYRE (e59.5610214).
Similar to the N2N3 domains of staphylococcal
MSCRAMMs, the identified first N2N3-like segment in
Fss1 and the N2N3-like segment in Fss2 are both located
near the N terminus. Furthermore, each contains a
TYTFTDYVD-like ‘latching-cleft’ motif (Ponnuraj et al.,
2003), which aligns with the corresponding motifs of
known MSCRAMM N2 domains in multiple sequence
alignments (Sillanpa¨a¨ et al., 2004). Fold predictions also
identified an N2N3-like region in the N-terminal half of
Fss3, with a weaker but significant match to SdrG N2N3
(Fss3 aa 267–586; e51.261022, 3D-PSSM). Neither the
second N2N3-like segment in Fss1 nor the N2N3-like
region in Fss3 contains an obvious latching-cleft sequence.
Fig. 1. Binding of the non-repeated A-region segments of Fss1,
Fss2 and Fss3 to immobilized ECM proteins in an ELISA-type
assay. The concentration of each protein assayed was 10 mM. The
assay was performed in triplicate and the values represent
means±SD. Lam, Laminin; Fn, fibronectin; Fg, fibrinogen; CI, CIII
and CIV, collagen types I, III and IV, respectively.
J. Sillanpa¨a¨ and others
2394 Microbiology 155
Expression and purification of the MSCRAMM
N2N3-like regions of Fss1, Fss2 and Fss3 as
recombinant proteins
To characterize the N2N3-like regions in the enterococcal
Fg-binding MSCRAMMs further, we subcloned and
expressed segments containing these regions as recombin-
ant proteins with N-terminal His6-tag fusions. Often, the
initial recombinant segments were partially degraded upon
storage, but produced stable degradation products with a
slightly smaller apparent molecular size. We interpreted
these results to indicate that the smaller stable constructs,
and not the original larger ones, represent relatively well-
defined and folded domains. We determined, by using a
combination of anti-His6 Western blot, N-terminal
sequencing and MALDI-TOF mass spectrometry, the likely
proteolytic-cleavage sites in the truncated segments (not
shown). We then expressed and purified the corresponding
segments: rFss1(220–550), rFss1(757–1090) and rFss2(111–429)
(Fig. 2b). We also created a second construct from Fss2,
rFss2(28–449), that included the preceding N-terminal
region. From Fss3, two segments were produced and
characterized further: rFss3(273–586), which is predicted to
correspond to an N2N3-like region, and rFss3(273–681),
which also included a C-terminally extended segment
(Fig. 2b). The purified proteins were analysed by MALDI-
TOF mass spectrometry, which showed major peaks
corresponding closely to the molecular masses calculated
from amino acid sequences for all protein segments, thus
demonstrating that the expected proteins were expressed
(not shown).
Analysis of secondary-structure components of
the predicted N2N3-like regions of Fss1, Fss2 and
Fss3
The far-UV CD spectra for recombinant protein segments
that encompass the N2N3-like regions in Fss1 (aa 220–550
and 757–1090), Fss2 (aa 28–449) and Fss3 (aa 273–681)
share a similar pattern, with a maximum between 194 and
203 nm and a minimum between 214 and 217 nm,
resembling the previously determined CD spectra for the
ligand-binding N2N3 domains of staphylococcal Fg-
binding MSCRAMMs (Fig. 3a). Deconvolution of the
collected data revealed a b-sheet content of 39–42% and an
a-helix content of 5–9% in the four N2N3-like segments
from the enterococcal MSCRAMMs (Fig. 3b). These values
are typical for IgG-like modules and are in good agreement
with the secondary-structure compositions of the ligand-
Fig. 2. Primary amino acid sequence char-
acteristics of the three Fg-binding E. faecalis
MSCRAMMs and analysis of purified recom-
binant segments encompassing their pre-
dicted ligand-binding regions. (a) Domain
organization of Fss1, Fss2 and Fss3.
Hatched areas represent non-repeated A-
regions; shaded areas represent B-repeat
regions. N2N3 within the A-regions depicts
predicted structural similarity to the N2N3
domains of the Fg-binding staphylococcal
MSCRAMMs ClfA and/or SdrG. Arrows above
the proteins define regions with predicted Ig-
type folding (e probability value certainty
.90%). S, Signal peptide; W, cell wall-
spanning domain; M, hydrophobic mem-
brane-spanning region; C, cytosolic tail with
positively charged residues; ., putative sor-
tase-cleavage motif LPXTG. (b) SDS-PAGE
analysis of the E. coli-expressed segments of
Fss1, Fss2 and Fss3. The recombinant pro-
teins with N-terminal His6 tags were purified by
nickel-affinity chromatography followed by
anion-exchange chromatography and sepa-
rated by using SDS-PAGE (12% gel) under
reducing conditions. Bands were visualized by
Coomassie brilliant blue R250 staining.
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binding domains in the solved crystal structures of ClfA,
SdrG, Cna and Ace.
The N2N3-like segments are the primary Fg-
binding regions of Fss1, Fss2 and Fss3
To determine whether the N2N3-like segments are respons-
ible for the Fg-binding activity of Fss1, Fss2 and Fss3, we
compared the Fg-binding activity of the N2N3 domains
with that of the intact A-regions, using an ELISA-type
ligand-binding assay. The N-terminal N2N3-like region of
rFss1(220–550) bound Fg weakly, whereas a significantly higher
level of Fg binding was seen with the second N2N3-like
segment [rFss1(757–1090)] (Fig. 4a). In fact, the level of Fg
binding recorded for rFss1(757–1090) was significantly higher
than that observed for the intact A-region [rFss1(36–1143)].
rFss2(111–429) bound Fg poorly, whereas rFss2(111–449) was a
potent Fg binder, indicating that the short C-terminal
extension contributed significantly to this activity. The N-
terminally extended rFss2(28–449) was an even more potent
Fg binder, suggesting that the N-terminal extension also
contributes to the Fg-binding activity of this protein.
The rFss3(273–586) segment, which corresponds to the
predicted N2N3 region, did not show significant Fg
binding (Fig. 4a). In contrast, the C-terminally extended
segment rFss3(273–681) showed considerably higher binding
to Fg than rFss3(273–586), which exceeded that of the larger
aa 267–971 region of Fss3. These observations indicate that
the N2N3-like region, defined by structural predictions to
encompass residues 273–583, requires additional C-ter-
minal residues for full Fg-binding activity.
Fig. 3. Analysis of secondary-structure compositions by far-UV
CD spectroscopy. (a) Recorded spectra of four recombinant
segments from the three E. faecalis Fg-binding MSCRAMMs.
#, rFss1(220–550); $, rFss1(757–1090); g, rFss2(28–449); m,
rFss3(273–681). Molar ellipticity (h) is shown in deg cm
2 dmol”1.
For details, see Methods. (b) Summary of secondary-structure
components. Deconvolution of the collected far-UV CD spectra
was performed with three algorithms, SELCON3, ContinLL and K2D,
using the DICHROWEB server (Lobley et al., 2002; Whitmore &
Wallace, 2004). Means±SEM are shown.
Fig. 4. Binding of the three E. faecalis MSCRAMMs to human Fg.
(a) A collection of recombinant segments from Fss1, Fss2 and
Fss3 were tested for their binding to Fg (filled bars) and BSA
(empty bars) by using an ELISA-type assay. The concentration of
each protein assayed was 10 mM. The assay was performed in
triplicate and the values represent means±SD. (b) Dose-depend-
ent binding of the minimal binding regions to Fg. Values of
MSCRAMM binding to wells coated with BSA were subtracted
from the respective Fg-binding values. Apparent KD values were
determined by using a one-site-binding non-linear regression
model (GraphPad Prism v4). The resulting curves are depicted in
the figure. The assay was performed in triplicate and the values
represent means±SD. &, rFss1(220–550); ., rFss1(757–1090); $,
rFss2(28–449); h, rFss3(273–681).
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As the purified proteins rFss1(757–1090), rFss2(28–449) and
rFss3(273–681) exhibited potent Fg-binding activity, they
were considered to contain the ligand-binding domains of
these three enterococcal Fg-binding MSCRAMMs and were
selected for further studies. As seen in Fig. 4(b), the three
proteins exhibited dose-dependent binding to immobilized
Fg with saturation kinetics. rFss1(757–1090) and rFss2(28–449)
showed the highest apparent affinities for Fg, with half-
maximal binding (apparent KD) at 7610
27 and
861027 M, respectively. The interaction of rFss3(273–681)
with Fg showed half-maximal binding at a concentration of
361026 M. For comparison, we also examined the dose-
dependent binding of rFss1(220–550), which corresponds to
the N-terminal N2N3-like region. This protein bound Fg
weakly, with an estimated apparent KD of 3–5610
25 M.
When compared with staphylococcal Fg-binding
MSCRAMMs, the apparent KD values (concentrations
required for half-maximal binding using an ELISA-type
assay) were in a range similar to those determined under
comparable conditions for ClfB (N2N3, 261028 M;
N1N2N3, .161027 M) (Perkins et al., 2001), FnbpA
(N2N3 region, aa 194–511, 4.061029 M) (Keane et al.,
2007) and ClfA (N2N3, aa 221–559, 861026 M, inhibition
ELISA) (Deivanayagam et al., 2002) of S. aureus and SdrG
(N1N2N3 region, aa 50–597, 0.961027 M) (Davis et al.,
2001) of S. epidermidis.
The Fg-binding N2N3-like regions of Fss1, Fss2
and Fss3 target different sites in Fg
We next examined whether Fss1, Fss2 and Fss3 showed
differences in their binding specificities to Fg by using a far-
Western ligand-blot assay. In this assay, the a, b and c chains
of Fg were separated by SDS-PAGE, transferred to a
supporting membrane and probed with the Fg-binding
segments identified above. As seen in Fig. 5, rFss1(757–1090)
bound preferentially to the b chain, whereas rFss3(273–681)
recognized the c chain. rFss2(28–449), on the other hand,
detected all three chains, possibly suggesting a more
complex binding mechanism for this MSCRAMM.
rFss1(220–550) bound weakly to the three Fg polypeptide
chains. As controls, we used rSdrG(273–597), which binds to a
site in the N-terminal region of the b chain (Davis et al.,
2001), and rFnbpA(194–513), which recognizes the C terminus
of the c chain (Wann et al., 2000). rEF1093(33–590), which did
not show appreciable binding to Fg in the ligand-binding
ELISA assays (see above), served as a negative control. In
conclusion, these results indicate that Fss1, Fss2 and Fss3
recognize different sites on the Fg molecule.
Adherence of E. faecalis OG1RF to immobilized
Fg is reduced by insertional inactivation of the
fss2 gene
To investigate whether the Fg binding observed above with
recombinant proteins is responsible for the interaction of E.
faecalis with Fg, we constructed an isogenic disruption
mutation in the genetically manipulatable E. faecalis strain
OG1RF (Murray et al., 1993). Lack of Fss2 surface expression
by strain TX5450, in which fss2 is inactivated, and the
presence of Fss2 on the surface of the OG1RF parent strain
were confirmed by whole-cell ELISA and immunofluores-
cence microscopy (data not shown), as well as by flow
cytometry (Fig. 6a) using affinity-purified Fss2-specific
antibodies. TX5450 showed significantly reduced (52%
reduction) adherence (P,0.0001) to immobilized Fg com-
pared with the wild-type OG1RF strain (Fig. 6b), yet the two
strains had similar doubling times and reached similar cell
densities at stationary phase (data not shown). Preliminary
experiments with the strain containing the inactivated fss1
gene showed marginally reduced attachment to Fg-coated
surfaces (S. R. Nallapareddy, J. Sillanpa¨a¨, M. Ho¨o¨k & B. E.
Murray, unpublished results), and genome analysis of the
sequenced OG1RF strain (Bourgogne et al., 2008) has shown
that this strain contains only a remote homologue of fss3
(60% amino acid identity) as a pseudogene.
To confirm that the fss2 disruption was responsible for the
reduced Fg adherence, we introduced pTEX5486 contain-
ing a wild-type copy of the fss2 gene into TX5450 (fss2
mutant of OG1RF). Nisin induction (Bryan et al., 2000)
resulted in almost-complete restoration of the Fg adher-
ence (Fig. 6b) of TX5488 (TX5450 with pTEX5486),
whereas the presence of vector alone in TX5450
(TX5487) showed no increase.
DISCUSSION
In the present study, we have initiated a search for ligands
of putative E. faecalis MSCRAMMs. Three of these
Fig. 5. Binding of the minimal ligand-binding regions of Fss1,
Fss2 and Fss3 to individual chains of Fg in a far-Western ligand-
binding assay. For experimental details, see text.
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proteins, Fss1, Fss2 and Fss3, bind human Fg and also
resemble previously characterized staphylococcal
MSCRAMMs in several ways, although they do not show
extensive sequence similarity. First, they share a similar
domain organization, with signal-peptide sequences and
cell-wall anchor domains flanking a non-repeated A-region
that is often followed by tandem repeats. The A-regions of
Fss1, Fss2 and Fss3 are much longer than the A-regions of
the staphylococcal MSCRAMMs, but are apparently also
composed of repeated IgG-like folded modules.
Furthermore, we have located the Fg-binding activities to
short segments within the A-regions of the enterococcal
proteins, which are predicted to adopt structures similar to
the ligand-binding N2N3 domains of the staphylococcal
MSCRAMMs. Three of the four N2N3-like regions with the
highest scores in the folding-type analyses, rFss1(220–550),
rFss2(111–449), and rFss3(273–681), are each located near the N
terminus, as are the N2N3 domains of staphylococcal
MSCRAMMs. rFss1(220–550) and rFss2(111–449) also contain
sequences homologous to the conserved latching-cleft motif
(consensus TYTFTDYVD) of the N2 domains of staphylo-
coccal MSCRAMMs, and align well with them in multiple
alignments. Moreover, we located a putative latch sequence
at the C-terminal end of rFss1(220–550). This motif represents
an extension of the N3 domains of MSCRAMMs and is a
critical component of the ‘dock, lock and latch’ ligand-
binding model proposed for SdrG (Bowden et al., 2008;
Ponnuraj et al., 2003). In this model, the latch sequence
secures the bound Fg peptide ligand in the interface between
the N2 and N3 domains by complementing a b-strand of the
neighbouring N2 domain (Bowden et al., 2008; Ponnuraj
et al., 2003). Although rFss1(220–550) bound only weakly to
Fg, deleting the putative latch sequence to generate
rFss1(220–507) resulted in even further reduced Fg binding
(data not shown). The predicted N2N3-like regions in
rFss1(757–1090) and rFss3(273–681), although less similar to
staphylococcal MSCRAMM N2N3 regions than rFss1(220–550)
and rFss2(111–449), share the similar predicted fold and
secondary-structure composition, and also bind Fg.
The presence of two predicted N2N3-like regions in Fss1 is
the first reported such case among MSCRAMMs. The first
of these regions (corresponding to residues 220–550)
probably recognizes a different protein as its primary
ligand, as the affinity for Fg was low. The second of the
N2N3 segments (corresponding to residues 757–1090)
showed higher affinity for Fg than the complete A-region
(aa 36–1143). It is tempting to speculate that the ligand-
binding activity of this N2N3 region might be regulated by
N-terminal proteolytic processing of the A-region, leading
to structural reorganization and activation of the Fg-
binding mechanism.
In S. aureus, four Fg-binding MSCRAMMs, ClfA (McDevitt
& Foster, 1995), ClfB (Ni Eidhin et al., 1998), FnbpA and
FnbpB (Wann et al., 2000), are known, and other Fg-binding
proteins have also been described. The presence of the three
Fg-binding MSCRAMMs described here suggests a similar
situation of functional redundancy for E. faecalis. Further,
our results indicate that the three enterococcal Fg-binding
MSCRAMMs bind to different regions of the Fg molecule.
The ability to express multiple Fg-binding MSCRAMMs
with different binding specificities might increase survival
and infectivity of E. faecalis within the host, e.g. in
endocarditis vegetations where Fg is immobilized in large
amounts. The staphylococcal MSCRAMM SdrG is known to
bind to the thrombin-cleavage site at the N-terminal end of
the b chain of Fg and can thereby interfere with release of the
immunoregulating fibrinopeptide B and with fibrin-clot
formation in the host (Davis et al., 2001), whilst ClfA
specifically recognizes the C-terminal end of the c chain and
competes for the same binding site on Fg as the platelet
integrin aIIb3, which is involved in platelet adherence and
Fig. 6. Effect of insertional inactivation of fss2 on surface
expression of Fss2 and adherence of E. faecalis OG1RF to Fg.
(a) Flow-cytometry analysis of Fss2 surface expression. Reactivity
of both preimmune (PI) and anti-Fss2 antibodies is shown.
OG1RF, Wild-type; TX5450, fss2 disruption mutant. Bacteria
were analysed by using side scatter as the threshold for detection.
Specific binding by anti-Fss2 antibodies is indicated on the x-axis
as fluorescence intensity (exponential scale). For each histogram,
50000 events of bacterium-sized particles were counted. (b)
Adherence of E. faecalis OG1RF and its derivatives to immobilized
Fg. OG1RF, Wild-type; TX5450, fss2 disruption mutant; TX5487,
TX5450 with vector pMSP3535; TX5488, fss2-complemented
TX5450. Adherence was tested in wells coated with 1 mg Fg (see
Methods). Bars represent mean±SD percentages of cells bound
for 32 wells (16 wells for complementation experiments). Results
are representative of four independent experiments. BSA was used
as a negative control.
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aggregation. It is an intriguing question whether comparable
physiological effects are elicited in the host by the three
enterococcal Fg-binding MSCRAMMs described here. Our
ongoing studies are aimed at further structural and
biochemical characterizations of the N2N3-like regions
and their interactions with Fg.
To investigate further the role of these MSCRAMMs in Fg
binding with E. faecalis as the producing bacterium, we
performed mutation analyses using the genetically amenable
OG1RF strain, which, like most E. faecalis strains, does not
express significant adherence to Fg under standard labor-
atory growth conditions unless supplemented with a
biological cue, such as serum (Nallapareddy & Murray,
2008). Inactivation of the expression of Fss2 in E. faecalis
OG1RF by gene disruption resulted in reduced adherence to
Fg, which was restored to near-wild-type levels by
complementation, indicating that Fss2 is involved in
adherence of E. faecalis cells to Fg. The residual Fg binding
exhibited by the mutant strain may represent functional
redundancy in Fg binding, contributed by other Fg-binding
adhesins. This is not likely to include Fss1, however, as we
detected no surface expression of Fss1 using whole-cell
ELISA with affinity-purified Fss1-specific antibodies when
OG1RF was grown in the presence or absence of serum to
several time points, representing early, mid-exponential and
late-exponential growth stages (data not shown). Consistent
with this observation, inactivation of the fss1 gene in OG1RF
did not result in significant reduction in Fg adherence under
the conditions tested (S. R. Nallapareddy, J. Sillanpa¨a¨, M.
Ho¨o¨k & B. E. Murray, unpublished results), and a divergent
homologue of fss3 is present as a pseudogene in the E.
faecalis strain used for genetic manipulations. It is therefore
likely that E. faecalis contains additional Fg-binding adhesins
beyond the MSCRAMMs described here.
In conclusion, we have identified three Fg-binding
MSCRAMMs, Fss1, Fss2 and Fss3, from E. faecalis. The
three proteins are considerably larger than previously
described staphylococcal and enterococcal MSCRAMMs,
but they share a similar predicted domain organization
with predicted IgG-like folded domains. We further
identified shorter, Fg-binding regions in these proteins
that show structural similarity to the Fg-binding regions in
staphylococcal MSCRAMMs and are similarly composed of
mostly b-sheets. Finally, disruption of fss2 gene expression
in E. faecalis resulted in reduced Fg adherence, which could
be restored by complementation.
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